Skip to main content
Title Pub Year Author Sort descending SearchLink
Electronic cigarette use among teenagers and young adults in Poland 2012 Tobacco Dependence Research Unit, Wolfson Institute of Preventive Medicine, Queen Mary University of London, 55 Philpot Street, London, E1 2JH, UK. m.goniewicz@qmul.ac.uk
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
Pediatrics
Periodical, Abbrev.
Pediatrics
Pub Date Free Form
Oct
Volume
130
Issue
4
Start Page
e879
Other Pages
85
Notes
LR: 20151119; JID: 0376422; 0 (Ganglionic Stimulants); 6M3C89ZY6R (Nicotine); 2012/09/17 [aheadofprint]; ppublish
Place of Publication
United States
ISSN/ISBN
1098-4275; 0031-4005
Accession Number
PMID: 22987874
Language
eng
SubFile
Journal Article; Research Support, Non-U.S. Gov't; AIM; IM
DOI
10.1542/peds.2011-3448 [doi]
Output Language
Unknown(0)
PMID
22987874
Abstract
BACKGROUND: Electronic cigarettes (e-cigarettes) are battery-powered devices developed with the goal of mimicking the action of smoking, including nicotine delivery, without the toxic effects of tobacco smoke. Little is known about the uptake of e-cigarettes among young people. METHODS: A survey was conducted with a cluster sample of 20240 students enrolled at 176 nationally representative Polish high schools and universities between September 2010 and June 2011. We estimated national e-cigarette prevalence among various demographic groups by using population weights. Multiple logistic regression was used to evaluate which demographic factors were independent predictors of 2 outcomes: ever use of e-cigarettes and use in the previous 30 days. RESULTS: Among high school students, aged 15 to 19 years, 23.5% had ever used e-cigarettes and 8.2% had done so within the previous 30 days. Among those in universities, aged 20 to 24 years, 19.0% had ever used an e-cigarette and 5.9% had done so in the previous 30 days. In multivariate analyses that controlled for covariates, smoking cigarettes, male gender, living in an urban area, and having parents who smoke were associated with ever use of e-cigarettes. Overall, 3.2% of never smoking students reported ever use of e-cigarettes. CONCLUSIONS: About one-fifth of Polish youth have tried e-cigarettes; most of them had previously smoked cigarettes. It is unclear whether e-cigarettes are just a novelty that young people try only once or whether they have potential to compete in the marketplace with conventional cigarettes.
Descriptors
Links
Book Title
Database
Publisher
Data Source
Authors
Goniewicz,M.L., Zielinska-Danch,W.
Original/Translated Title
URL
Date of Electronic
20120917
PMCID
Editors
Secondhand smoke exposure and neurobehavioral disorders among children in the United States 2011 Tobacco Free Research Institute, Dublin, Ireland. halpert@hsph.harvard.edu
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
Pediatrics
Periodical, Abbrev.
Pediatrics
Pub Date Free Form
Aug
Volume
128
Issue
2
Start Page
263
Other Pages
270
Notes
JID: 0376422; 0 (Tobacco Smoke Pollution); 2011/07/11 [aheadofprint]; ppublish
Place of Publication
United States
ISSN/ISBN
1098-4275; 0031-4005
Accession Number
PMID: 21746720
Language
eng
SubFile
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; AIM; IM
DOI
10.1542/peds.2011-0023 [doi]
Output Language
Unknown(0)
PMID
21746720
Abstract
OBJECTIVES: The association between parent-reported postnatal secondhand tobacco smoke exposure in the home and neurobehavioral disorders (attention-deficit/hyperactivity disorder, learning disabilities, and conduct disorders) among children younger than 12 years in the United States was examined using the 2007 National Survey on Children's Health. Excess neurobehavioral disorders attributable to secondhand smoke (SHS) exposure in the home in 2007 were further investigated. METHODS: The methods used in this study were multivariable logistic regression models that accounted for potential confounders and complex survey designs to evaluate associations. RESULTS: A total of 6% of 55 358 children (aged /=2 childhood neurobehavioral disorders compared with children who were not exposed to SHS. Boys had a significantly higher risk. Older children, especially those aged 9 to 11 years, and those living in households with the highest poverty levels were at greater risk. In absolute terms, 274 100 excess cases in total of these 3 disorders could have been prevented if children had not been exposed to SHS in their homes. CONCLUSIONS: The findings of the study, which are associational and not necessarily causal, underscore the health burden of childhood neurobehavioral disorders that may be attributable to SHS exposure in homes in the United States.
Descriptors
Links
Book Title
Database
Publisher
Data Source
Authors
Kabir,Z., Connolly,G.N., Alpert,H.R.
Original/Translated Title
URL
Date of Electronic
20110711
PMCID
Editors
The development of tobacco use in adolescence among "snus starters" and "cigarette starters": an analysis of the Swedish "BROMS" cohort 2008 Tobacco Prevention, Stockholm Centre for Public Health, and Clinical Epidemiology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden. rosaria.galanti@sll.se
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
Periodical, Abbrev.
Nicotine Tob.Res.
Pub Date Free Form
Feb
Volume
10
Issue
2
Start Page
315
Other Pages
323
Notes
LR: 20151119; JID: 9815751; ppublish
Place of Publication
England
ISSN/ISBN
1462-2203; 1462-2203
Accession Number
PMID: 18236296
Language
eng
SubFile
Journal Article; Research Support, Non-U.S. Gov't; IM
DOI
10.1080/14622200701825858 [doi]
Output Language
Unknown(0)
PMID
18236296
Abstract
Whether the use of smokeless tobacco can facilitate the transition to cigarette smoking and/or to prolonged tobacco use in adolescence is unclear. We analyzed data from a cohort of 2,938 Swedish adolescents, with six follow-up assessments of tobacco use between the ages of 11 and 18 years. The majority of tobacco users (70%) started by smoking cigarettes, 11% took up snus before smoking, and 19% used both tobacco types close in time. Ever users of tobacco at baseline had a higher risk of being current smokers and/or smokeless tobacco users at the end of follow-up compared with never users, with the highest excess relative risk for "mixed users." Adolescents who initiated tobacco use with cigarettes had a non-significantly increased probability to end up as current smokers compared with snus starters (adjusted OR=1.42; 95% CI 0.98-2.10) The OR of smoking for "mixed starters" was 2.54 (95% CI 1.68-3.91). The risk of becoming current user of any tobacco was also significantly enhanced for "mixed starters." Marked sex differences were observed in these associations, as initiation with cigarettes rather than with snus predicted current smoking or tobacco use only among females. Progression of tobacco use in adolescence is not predicted by onset with snus or cigarettes, but rather by initiation with both tobacco types close in time and/or at young age. The proportion of adolescent smoking prevalence attributable to a potential induction effect of snus is likely small.
Descriptors
Adolescent, Confidence Intervals, Cross-Sectional Studies, Female, Health Knowledge, Attitudes, Practice, Humans, Life Style, Male, Odds Ratio, Peer Group, Prevalence, Risk Factors, Risk-Taking, School Health Services/organization & administration, Smoking/epidemiology/psychology, Smoking Cessation/methods, Social Environment, Students/psychology/statistics & numerical data, Surveys and Questionnaires, Sweden/epidemiology, Tobacco Use Disorder/epidemiology/prevention & control, Tobacco, Smokeless
Links
Book Title
Database
Publisher
Data Source
Authors
Galanti,M. R., Rosendahl,I., Wickholm,S.
Original/Translated Title
URL
Date of Electronic
PMCID
Editors
Increasing prevalence of electronic cigarette use among smokers hospitalized in 5 US cities, 2010-2013 2015 Tobacco Research and Treatment Center, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA; nrigotti@partners.org.; Division of Pulmonary, Allergy, and Critical Care Medicine, University of Alabama at Birmingham,
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
Periodical, Abbrev.
Nicotine Tob.Res.
Pub Date Free Form
Feb
Volume
17
Issue
2
Start Page
236
Other Pages
244
Notes
LR: 20160519; CI: (c) The Author 2014; GR: R01 HL111821/HL/NHLBI NIH HHS/United States; GR: R01HL111821/HL/NHLBI NIH HHS/United States; GR: RC1 HL099668/HL/NHLBI NIH HHS/United States; GR: RC1HL099668/HL/NHLBI NIH HHS/United States; GR: U01 DA031515/DA/NI
Place of Publication
England
ISSN/ISBN
1469-994X; 1462-2203
Accession Number
PMID: 25168031
Language
eng
SubFile
Journal Article; Research Support, N.I.H., Extramural; IM
DOI
10.1093/ntr/ntu138 [doi]
Output Language
Unknown(0)
PMID
25168031
Abstract
INTRODUCTION: Little is known about the pattern of electronic cigarette (e-cigarette) use over time or among smokers with medical comorbidity. METHODS: We assessed current cigarette smokers' use of e-cigarettes during the 30 days before admission to 9 hospitals in 5 geographically dispersed US cities: Birmingham, AL; Boston, MA; Kansas City, KS; New York, NY; and Portland, OR. Each hospital was conducting a randomized controlled trial as part of the NIH-sponsored Consortium of Hospitals Advancing Research on Tobacco (CHART). We conducted a pooled analysis using multiple logistic regression to examine changes in e-cigarette use over time and to identify correlates of e-cigarette use. RESULTS: Among 4,660 smokers hospitalized between July 2010 and December 2013 (mean age 57 years, 57% male, 71% white, 56% some college, average 14 cigarettes/day), 14% reported using an e-cigarette during the 30 days before admission. The prevalence of e-cigarette use increased from 1.1% in 2010 to 10.3% in 2011, 10.2% in 2012, and 18.4% in 2013; the increase was statistically significant (p
Descriptors
Links
Book Title
Database
Publisher
. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco
Data Source
Authors
Rigotti,N.A., Harrington,K.F., Richter,K., Fellows,J.L., Sherman,S.E., Grossman,E., Chang,Y., Tindle,H.A., Ylioja,T., Consortium of Hospitals Advancing Research on Tobacco
Original/Translated Title
URL
Date of Electronic
20140828
PMCID
PMC4837996
Editors
Interventions for smoking cessation in hospitalised patients 2012 Tobacco Research and Treatment Center, Department of Medicine, Massachusetts General Hospital and Harvard Medical School,Boston,Massachusetts, USA. nrigotti@partners.org.
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
The Cochrane database of systematic reviews
Periodical, Abbrev.
Cochrane Database Syst.Rev.
Pub Date Free Form
16-May
Volume
(5):CD001837. doi
Issue
5
Start Page
CD001837
Other Pages
Notes
LR: 20160602; GR: K24 HL004440/HL/NHLBI NIH HHS/United States; JID: 100909747; CIN: Evid Based Nurs. 2013 Jan;16(1):21-2. PMID: 22961882; CIN: Evid Based Med. 2013 Jun;18(3):e25. PMID: 23002093; NIHMS704512; OID: NLM: NIHMS704512; OID: NLM: PMC4498489; ep
Place of Publication
England
ISSN/ISBN
1469-493X; 1361-6137
Accession Number
PMID: 22592676
Language
eng
SubFile
Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review; IM
DOI
10.1002/14651858.CD001837.pub3 [doi]
Output Language
Unknown(0)
PMID
22592676
Abstract
BACKGROUND: Smoking contributes to reasons for hospitalisation, and the period of hospitalisation may be a good time to provide help with quitting. OBJECTIVES: To determine the effectiveness of interventions for smoking cessation that are initiated for hospitalised patients. SEARCH METHODS: We searched the Cochrane Tobacco Addiction Group register which includes papers identified from CENTRAL, MEDLINE, EMBASE and PsycINFO in December 2011 for studies of interventions for smoking cessation in hospitalised patients, using terms including (hospital and patient*) or hospitali* or inpatient* or admission* or admitted. SELECTION CRITERIA: Randomized and quasi-randomized trials of behavioural, pharmacological or multicomponent interventions to help patients stop smoking, conducted with hospitalised patients who were current smokers or recent quitters (defined as having quit more than one month before hospital admission). The intervention had to start in the hospital but could continue after hospital discharge. We excluded studies of patients admitted to facilities that primarily treat psychiatric disorders or substance abuse, studies that did not report abstinence rates and studies with follow-up of less than six months. Both acute care hospitals and rehabilitation hospitals were included in this update, with separate analyses done for each type of hospital. DATA COLLECTION AND ANALYSIS: Two authors extracted data independently for each paper, with disagreements resolved by consensus. MAIN RESULTS: Fifty trials met the inclusion criteria. Intensive counselling interventions that began during the hospital stay and continued with supportive contacts for at least one month after discharge increased smoking cessation rates after discharge (risk ratio (RR) 1.37, 95% confidence interval (CI) 1.27 to 1.48; 25 trials). A specific benefit for post-discharge contact compared with usual care was found in a subset of trials in which all participants received a counselling intervention in the hospital and were randomly assigned to post-discharge contact or usual care. No statistically significant benefit was found for less intensive counselling interventions. Adding nicotine replacement therapy (NRT) to an intensive counselling intervention increased smoking cessation rates compared with intensive counselling alone (RR 1.54, 95% CI 1.34 to 1.79, six trials). Adding varenicline to intensive counselling had a non-significant effect in two trials (RR 1.28, 95% CI 0.95 to 1.74). Adding bupropion did not produce a statistically significant increase in cessation over intensive counselling alone (RR 1.04, 95% CI 0.75 to 1.45, three trials). A similar pattern of results was observed in a subgroup of smokers admitted to hospital because of cardiovascular disease (CVD). In this subgroup, intensive intervention with follow-up support increased the rate of smoking cessation (RR 1.42, 95% CI 1.29 to 1.56), but less intensive interventions did not. One trial of intensive intervention including counselling and pharmacotherapy for smokers admitted with CVD assessed clinical and health care utilization endpoints, and found significant reductions in all-cause mortality and hospital readmission rates over a two-year follow-up period. These trials were all conducted in acute care hospitals. A comparable increase in smoking cessation rates was observed in a separate pooled analysis of intensive counselling interventions in rehabilitation hospitals (RR 1.71, 95% CI 1.37 to 2.14, three trials). AUTHORS' CONCLUSIONS: High intensity behavioural interventions that begin during a hospital stay and include at least one month of supportive contact after discharge promote smoking cessation among hospitalised patients. The effect of these interventions was independent of the patient's admitting diagnosis and was found in rehabilitation settings as well as acute care hospitals. There was no evidence of effect for interventions of lower intensity or shorter duration. This update
Descriptors
Links
Book Title
Database
Publisher
Data Source
Authors
Rigotti,N.A., Clair,C., Munafo,M.R., Stead,L.F.
Original/Translated Title
URL
Date of Electronic
20120516
PMCID
PMC4498489
Editors
Homelessness, cigarette smoking and desire to quit: results from a US national study 2013 Tobacco Research and Treatment Center, General Medicine Division, Massachusetts General Hospital, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA, USA; Boston Health Care for the Homeless Program, Boston, MA, USA.
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
Addiction (Abingdon, England)
Periodical, Abbrev.
Addiction
Pub Date Free Form
Nov
Volume
108
Issue
11
Start Page
2009
Other Pages
2018
Notes
LR: 20150423; CI: (c) 2013; GR: K23 DA034008/DA/NIDA NIH HHS/United States; GR: K23DA034008/DA/NIDA NIH HHS/United States; JID: 9304118; NIHMS506966; OID: NLM: NIHMS506966; OID: NLM: PMC3797258; OTO: NOTNLM; 2013/02/15 [received]; 2013/04/09 [revised]; 20
Place of Publication
England
ISSN/ISBN
1360-0443; 0965-2140
Accession Number
PMID: 23834157
Language
eng
SubFile
Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; IM
DOI
10.1111/add.12292 [doi]
Output Language
Unknown(0)
PMID
23834157
Abstract
AIMS: We determined whether or not homelessness is associated with cigarette smoking independent of other socio-economic measures and behavioral health factors, and whether homeless smokers differ from non-homeless smokers in their desire to quit. DESIGN, SETTING AND PARTICIPANTS: We analyzed data from 2678 adult respondents to the 2009 Health Center Patient Survey, a nationally representative cross-sectional survey of homeless and non-homeless individuals using US federally funded community health centers. MEASUREMENTS: We used multivariable logistic regression to examine the association between homelessness and (i) current cigarette smoking among all adults, and (ii) past-year desire to quit among current smokers, adjusting for demographic, socio-economic and behavioral health characteristics. FINDINGS: Adults with any history of homelessness were more likely than never homeless respondents to be current smokers (57 versus 27%, P
Descriptors
Links
Book Title
Database
Publisher
Society for the Study of Addiction
Data Source
Authors
Baggett,T.P., Lebrun-Harris,L.A., Rigotti,N.A.
Original/Translated Title
URL
Date of Electronic
20130814
PMCID
PMC3797258
Editors
Comparative Effectiveness of Post-Discharge Strategies for Hospitalized Smokers: study protocol for the Helping HAND 2 randomized controlled trial 2015 Tobacco Research and Treatment Center, Massachusetts General Hospital, Boston, MA, USA. zreid@partners.org.; Mongan Institute for Health Policy, Massachusetts General Hospital and Partners HealthCare, Boston, MA, USA. zreid@partners.org.; Tobacco Research
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
BMC public health
Periodical, Abbrev.
BMC Public Health
Pub Date Free Form
7-Feb
Volume
15
Issue
Start Page
109
Other Pages
015-1484-0
Notes
LR: 20151111; ClinicalTrials.gov/NCT01714323; GR: 1R01HL111821-01/HL/NHLBI NIH HHS/United States; GR: 3R01HL111821-01S1/HL/NHLBI NIH HHS/United States; GR: R01 HL111821/HL/NHLBI NIH HHS/United States; JID: 100968562; OID: NLM: PMC4328622; 2015/01/21 [rece
Place of Publication
England
ISSN/ISBN
1471-2458; 1471-2458
Accession Number
PMID: 25879193
Language
eng
SubFile
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; IM
DOI
10.1186/s12889-015-1484-0 [doi]
Output Language
Unknown(0)
PMID
25879193
Abstract
BACKGROUND: Smoking cessation interventions for hospitalized smokers are effective in promoting smoking cessation, but only if the tobacco dependence treatment continues after the patient leaves the hospital. Sustaining tobacco dependence treatment after hospital discharge is a challenge for health care systems. Our previous single-site randomized controlled trial demonstrated the effectiveness of an intervention that facilitated the delivery of comprehensive tobacco cessation treatment, including both medication and counseling, after hospital discharge. We subsequently streamlined the intervention model to increase its potential for dissemination. This new model is being tested in a larger multi-site trial with broader eligibility criteria in order to enroll a more representative sample of hospitalized smokers. This paper describes the trial design and contrasts it with the earlier study. METHODS/DESIGN: A 2-arm, 3-site randomized controlled trial is testing the hypothesis that a multi-component Sustained Care intervention is more effective than Standard Care in helping hospitalized cigarette smokers stop smoking after hospital discharge. The trial enrolls adult daily cigarette smokers who are admitted to 1 of 3 participating hospitals in Massachusetts or Pennsylvania. Participants receive the same smoking cessation intervention in the hospital. They are randomly assigned to receive either Standard Care or Sustained Care after hospital discharge. Participants in the Sustained Care arm receive a free 3-month supply of FDA-approved smoking cessation medication and 5 interactive voice response calls that provide tailored motivational messages, medication refills, and access to a live tobacco treatment counselor. Participants in the Standard Care arm receive a smoking cessation medication recommendation and information about community resources. Outcomes are assessed at 1, 3, and 6 months after discharge. The primary outcome is biochemically-validated tobacco abstinence for the past 7 days at 6-month follow-up. Other outcome measures include self-reported tobacco abstinence measures, use of medication and counseling after discharge, hospital readmissions, and program cost-effectiveness. DISCUSSION: We adapted a proven intervention for hospitalized smokers to enhance its potential for dissemination and are testing it in a multi-site trial. Study enrollment data suggests that the trial achieved the goal of recruiting a broader sample of hospitalized smokers. TRIAL REGISTRATION: Comparative Effectiveness of Post-Discharge Strategies for Hospitalized Smokers (Helping HAND2) NCT01714323. Registered October 22, 2012.
Descriptors
Links
Book Title
Database
Publisher
Data Source
Authors
Reid,Z.Z., Regan,S., Kelley,J.H., Streck,J.M., Ylioja,T., Tindle,H.A., Chang,Y., Levy,D.E., Park,E.R., Singer,D.E., Carpenter,K.M., Reyen,M., Rigotti,N.A.
Original/Translated Title
URL
Date of Electronic
20150207
PMCID
PMC4328622
Editors
Electronic Cigarette Use among Irish Youth: A Cross Sectional Study of Prevalence and Associated Factors 2015 TobaccoFree Research Institute Ireland, DIT Focas, Camden Row, Dublin, Ireland.; TobaccoFree Research Institute Ireland, DIT Focas, Camden Row, Dublin, Ireland.; TobaccoFree Research Institute Ireland, DIT Focas, Camden Row, Dublin, Ireland.
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
PloS one
Periodical, Abbrev.
PLoS One
Pub Date Free Form
27-May
Volume
10
Issue
5
Start Page
e0126419
Other Pages
Notes
LR: 20150610; JID: 101285081; OID: NLM: PMC4446031; 2015 [ecollection]; 2015/01/05 [received]; 2015/03/31 [accepted]; 2015/05/27 [epublish]; epublish
Place of Publication
United States
ISSN/ISBN
1932-6203; 1932-6203
Accession Number
PMID: 26018542
Language
eng
SubFile
Journal Article; Research Support, Non-U.S. Gov't; IM
DOI
10.1371/journal.pone.0126419 [doi]
Output Language
Unknown(0)
PMID
26018542
Abstract
PURPOSE: To examine prevalence of, and factors associated with, e-cigarette use among young people aged 16-17 in Ireland. METHODS: In 2014, a representative sample of 821 young people aged 16-17 recruited from secondary schools completed a pen and paper survey on e-cigarette use, tobacco use, and socio-demographic items. FINDINGS: A total of 23.8% of respondents had used e-cigarettes at least once. Dual trial of tobacco and e-cigarettes was common with 69.5% of regular smokers and 30.4% of 'ever' smokers having tried e-cigarettes and 10.6% of current smokers using e-cigarettes regularly. 4.2% of never smokers have tried e-cigarettes. Overall, current e-cigarette use (once a month or more) was low (3.2%). Binary logistic regression conducted through generalized estimating equations (GEE) determined that controlling for other variables, current tobacco use and 'ever' tobacco use predicted ever e-cigarette use. Gender and school-level socioeconomic status were also independent predictors of ever e-cigarette use. Gender stood as the only predictor of on-going e-cigarette use, with males being more likely to regularly use e-cigarettes at least once a month. CONCLUSIONS: E-cigarette use among 16-17 year olds in Ireland is of note, with nearly a quarter of students having tried them. Concurrent or experimental use of e-cigarettes and tobacco is more common than sole use, while a small number have tried e-cigarettes without having tried tobacco.
Descriptors
Links
Book Title
Database
Publisher
Data Source
Authors
Babineau,K., Taylor,K., Clancy,L.
Original/Translated Title
URL
Date of Electronic
20150527
PMCID
PMC4446031
Editors
Chlorohydrins of bisphenol A diglycidyl ether (BADGE) and of bisphenol F diglycidyl ether (BFDGE) in canned foods and ready-to-drink coffees from the Japanese market 2001 Tokyo Metropolitan Research Laboratory of Public Health, Japan. uematsu@tokyo-eiken.go.jp
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
Food additives and contaminants
Periodical, Abbrev.
Food Addit.Contam.
Pub Date Free Form
Feb
Volume
18
Issue
2
Start Page
177
Other Pages
185
Notes
LR: 20131121; JID: 8500474; 0 (Benzhydryl Compounds); 0 (Carcinogens); 0 (Chlorohydrins); 0 (Coffee); 0 (Epoxy Compounds); 0 (bisphenol F diglycidyl ether); F3XRM1NX4H (2,2-bis(4-glycidyloxyphenyl)propane); ppublish
Place of Publication
England
ISSN/ISBN
0265-203X; 0265-203X
Accession Number
PMID: 11288915
Language
eng
SubFile
Journal Article; IM
DOI
10.1080/02652030010005501 [doi]
Output Language
Unknown(0)
PMID
11288915
Abstract
BADGE.2HCl and BFDGE.2HCl were determined in 28 samples of ready-to-drink canned coffee and 18 samples of canned vegetables (10 corn, 5 tomatoes and 3 others), all from the Japanese market. HPLC was used as the principal analytical method and GC-MS for confirmation of relevant LC fractions. BADGE.2HCl was found to be present in one canned coffee and five samples of corn, BFDGE.2HCl in four samples of canned tomatoes and in one canned corn. No sample was found which exceeded the 1 mg/kg limit of the EU for the BADGE chlorohydrins. However the highest concentration was found for the sum of BFDGE.2HCl anti BFDGE.HCl.H2O at a level of 1.5 mg/kg. A Beilstein test confirmed that all cans containing foods contaminated with BADGE.2HCl or BFDGE.2HCl had at lest one part coated with a PVC organosol.
Descriptors
Benzhydryl Compounds, Carcinogens/analysis, Chlorohydrins/analysis/chemistry, Chromatography, High Pressure Liquid, Coffee/chemistry, Epoxy Compounds/analysis, Food Contamination, Food Packaging, Gas Chromatography-Mass Spectrometry, Humans, Japan, Vegetables/chemistry
Links
Book Title
Database
Publisher
Data Source
Authors
Uematsu,Y., Hirata,K., Suzuki,K., Iida,K., Saito,K.
Original/Translated Title
URL
Date of Electronic
PMCID
Editors
Magnetic nanoparticles with hydrophobicity and hydrophilicity for solid-phase extraction of polycyclic aromatic hydrocarbons from environmental water samples 2015 Tongji School of Pharmacy, Huazhong University of Science and Technology, Wuhan 430030, China.; Tongji School of Pharmacy, Huazhong University of Science and Technology, Wuhan 430030, China.; Tongji School of Pharmacy, Huazhong University of Science and T
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
Journal of chromatography.A
Periodical, Abbrev.
J.Chromatogr.A
Pub Date Free Form
11-Sep
Volume
1411
Issue
Start Page
9
Other Pages
16
Notes
CI: Copyright (c) 2015; JID: 9318488; 0 (Magnetite Nanoparticles); 0 (Polycyclic Hydrocarbons, Aromatic); 0 (Water Pollutants, Chemical); OTO: NOTNLM; 2015/04/16 [received]; 2015/07/28 [revised]; 2015/07/31 [accepted]; 2015/08/01 [aheadofprint]; ppublish
Place of Publication
Netherlands
ISSN/ISBN
1873-3778; 0021-9673
Accession Number
PMID: 26260841
Language
eng
SubFile
Journal Article; Research Support, Non-U.S. Gov't; IM
DOI
10.1016/j.chroma.2015.07.104 [doi]
Output Language
Unknown(0)
PMID
26260841
Abstract
Magnetic nanoparticles (MNPs) featured with divinylbenzene (DVB) and sulfonate functionalities (Fe3O4-DVB-SO3(-)) were prepared via "thiol-ene" click chemistry. The hydrophobic DVB moieties were dedicated for extraction while the hydrophilic sulfonate groups were designed for dispersing the MNPs in aqueous sample solution. Thus, the specially designed material could ensure operational convenience and improve reproducibility during extraction. The application of the material was demonstrated by the extraction of polycyclic aromatic hydrocarbons (PAHs) from environmental water samples followed by gas chromatography-mass spectrometric analysis. The main factors influencing the extraction, including the type of the desorption solvent, the agitation mode, the amount of MNPs, extraction and desorption time and salt addition in sample solution, were investigated in detail. Under the optimized conditions, the proposed method showed satisfactory reproducibility with intra-day and inter-day relative standard deviations less than 16.5% and 21.2%, and low limits of detection of 1.1pgmL(-1), 0.8pgmL(-1), 1.1pgmL(-1), 1.4pgmL(-1), 0.6pgmL(-1), 2.1pgmL(-1) and 0.7pgmL(-1) for naphthalene, acenaphthene, fluorine, phenanthrene, anthracene, fluoranthene and pyrene, respectively. The developed method was also successfully used for determination of the PAHs in genuine lake and river environmental water samples by standard addition method. All the studied PAHs were detected in these waters with comparable results by the standard liquid-liquid extraction method. The developed MNPs with dual property of hydrophobicity and hydrophilicity were suitable for the treatment of water samples. The magnetic solid phase extraction based on this material was reliable and convenient. It has great potential in the preconcentration of trace analytes in complex matrix.
Descriptors
Links
Book Title
Database
Publisher
Elsevier B.V
Data Source
Authors
Xue,S.W., Tang,M.Q., Xu,L., Shi,Z.G.
Original/Translated Title
URL
Date of Electronic
20150801
PMCID
Editors